tweetindex
RU

Bruce Booth

@LifeSciVC · Cambridge, MA · joined 21 Dec 2010

Early stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.

56 804Followers
733Following
12 084Posts total
56KViews on collected posts

Последние посты

Reach The Beach 2026 got cancelled….  Ragnar didn’t pay its bills and NH refused the permits… but our team, Runners Drugs & Money, was ready to go.  We trained over 7000 miles since June.  We raised $128K for charity.  We were ready with plenty of booyah and cowbell.  And we http
9.4K views · 55 likes · 3 reposts · 5 replies Open on X →
💯- “Intelligence distribution over intelligence centralization” 7.5K views · 12 likes · 0 reposts · 0 replies Open on X →
Get with the Program! Importance of Project Leadership and Program Management in drug R&D. Perspectives from Lifordi CEO @ArthurTzianabos https://t.co/GCsK4biclV 4K views · 10 likes · 4 reposts · 3 replies Open on X →
@LifeSciVC classic biotech VC pumping hype 214 views · 1 likes · 0 reposts · 0 replies Open on X →
@LifeSciVC @BiotechCH The wind in the sails US biotech needs but this time not squander the opportunity 486 views · 6 likes · 1 reposts · 0 replies Open on X →
@LifeSciVC Fantastic news! Congratulations to $MRNA sticking to their guns on therapeutic cancer vaccines and their partner $MRK 490 views · 1 likes · 0 reposts · 0 replies Open on X →
Biotech is booming... $XBI closed at ~$170 With today's surge, we're within striking distance of the $XBI All Time High of $174.79, reached in Feb 2021 during the pandemic-era biotech bubble. Funnily enough, $MRNA was trading at ~$175/share back then (Feb 2021) and popped 18.4K views · 122 likes · 12 reposts · 14 replies Open on X →
Great discussion with @NelloMainolfi about the early days of @KymeraTx ! 7.3K views · 21 likes · 1 reposts · 1 replies Open on X →
It was great to sit down with @KymeraTx co-founder @LifeSciVC and revisit our early days, from the science that brought us together to the early decisions that still shape how we are building the company today. Ten years later, I’m proud of how far we’ve come and even more 8.2K views · 10 likes · 1 reposts · 0 replies Open on X →

На фоне аккаунтов своего размера

9 постов за последние 90 дней рядом с диапазоном 10K–100K подписчиков. показывается широко, но откликается мало кто.

Медианные просмотры7 335этот аккаунт1 015медиана для 10K–100K
Охват, %12.91%этот аккаунт3.95%медиана для 10K–100K
Вовлечённость, %0.43%этот аккаунт1.54%медиана для 10K–100K
ПоказательЭтот аккаунтМедиана для 10K–100KОтношение
Медианные просмотры на пост7 3351 0157.23×
Охват (просмотры ÷ подписчики)12.91%3.95%3.27×
Вовлечённость0.43%1.54%0.28×

Другие в этом диапазоне →   Сравнить с другим аккаунтом →   Как считаются эти ориентиры →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

8.2K17 Aug
7.3K
18.4K19 Aug
490
486
21420 Aug
4K10 Sep
7.5K13 Sep
9.4K19 Sep

Last 9 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.16%17 Aug
0.31%
0.81%19 Aug
0.20%
1.44%
0.47%20 Aug
0.43%10 Sep
0.16%13 Sep
0.67%19 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.54%.

What the audience does

Likes70.2%238 in total
Reposts6.5%22 in total
Replies6.8%23 in total
Quotes0.9%3 in total
Bookmarks15.6%53 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

Followers by day

23 Sep

Daily snapshots since 23 Sep 2026; the dashed line is the starting count.

Похожие аккаунты